People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NextCure, Inc. | — | Biotechnology | Series C | $129.9M | $113.9M | 2025 |
| Arvinas, Inc. | — | Biotechnology | Series C | $129.1M | $1.3B | 2019 |
John G. Houston at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John G. Houston on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ANDREW LEVIN | 1 | 17 |
| Kush Parmar | 1 | 10 |
| Tim Shannon | 1 | 9 |
| Stephen Squinto | 1 | 8 |
| Judith Li | 1 | 8 |
| David Kabakoff | 1 | 7 |
| Sean Cassidy | 1 | 7 |
| Michael Yi | 1 | 4 |
| Liam Ratcliffe | 1 | 4 |
| ASHER RUBIN | 1 | 3 |
| Jonathan Soderstrom | 1 | 3 |
| Elaine V. Jones | 1 | 3 |
| Liam D. Ratcliffe | 1 | 2 |
| CAROLYN GREEN | 1 | 2 |
| Steven P. Cobourn | 1 | 2 |
| MICHAEL RICHMAN | 1 | 2 |
| David P. Kabakoff | 1 | 2 |
| Brad Margus | 1 | 2 |
| TIM Q. SHANNON | 1 | 1 |
| Udayan G. Guha | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.